Gossamer Bio, Inc. (NASDAQ:GOSS)

About the company

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

171

CEO

Sheila Gujrathi

Exchange

NASDAQ

Website

http://www.gossamerbio.com

$NoneM

Total Revenue

171

Employees

$802.76M

Market Capitalization

-4.04

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 377376.69 82729.00 6.06 21.99 20.75
Merck & Co., Inc. MRK 202149.48 48081.00 7.59 19.94 21.10
Pfizer Inc. PFE 194670.90 50660.00 2.95 12.32 31.17
Eli Lilly & Co. LLY 149909.40 23087.00 50.87 26.42 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110414.38 31006.00 2.68 93.87 3.08
Repligen Corp. RGEN 6459.15 286.00 6.19 281.44 8.11
Reata Pharmaceuticals, Inc. RETA 4836.62 20.00 22.91 -15.56 -150.30
Nektar Therapeutics NKTR 4139.52 137.00 3.23 -9.01 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3702.40 1.00 34.23 -5.66 None
Allakos, Inc. ALLK 3144.30 None 6.83 -33.62 None
Karuna Therapeutics, Inc. KRTX 2767.96 None 7.23 -68.24 None
ADC Therapeutics SA ADCT 2756.70 2.00 32.52 -23.63 None
Turning Point Therapeutics, Inc. TPTX 2316.60 None 6.97 -19.38 None
IGM Biosciences, Inc. IGMS 2230.14 None 9.83 -41.11 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
OPKO Health, Inc. OPK 2155.86 891.00 1.53 -7.37 -32.92
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1743.65 None 5.66 -27.97 None
Principia Biopharma, Inc. PRNB 1568.00 30.00 5.58 -22.31 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1551.78 None 9.51 -16.84 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Akcea Therapeutics, Inc. AKCA 1370.61 341.00 2.81 -48.72 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1298.01 None 6.67 -6.15 None
Arcutis Biotherapeutics, Inc. ARQT 1184.37 None 5.05 -18.94 None
Odonate Therapeutics, Inc. ODT 1163.48 None 9.53 -10.34 None
Athenex, Inc. ATNX 1070.16 123.00 6.56 -9.94 -87.86
Phibro Animal Health Corp. PAHC 1068.87 818.00 5.40 28.97 4.49
Akero Therapeutics, Inc. AKRO 957.58 None 8.00 -18.87 None
Constellation Pharmaceuticals, Inc. CNST 927.36 None 3.86 -9.99 None
Oric Pharmaceuticals, Inc. ORIC 838.04 None -9.10 -27.71 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Aprea Therapeutics, Inc. APRE 816.06 None 7.22 -24.14 None
Gossamer Bio, Inc. GOSS 802.76 None 3.26 -4.04 None
Phathom Pharmaceuticals, Inc. PHAT 783.75 None 4.35 -2.88 None
Krystal Biotech, Inc. KRYS 760.75 None 4.44 -36.68 None
Quanterix Corp. QTRX 750.60 60.00 6.62 -17.16 -71.52
Applied Therapeutics, Inc. APLT 729.30 None 4.71 -14.80 None
Keros Therapeutics, Inc. KROS 675.18 8.00 -30.50 -31.79 -285.35
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 619.24 1679.00 4.26 -2.84 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 605.28 19.00 56.10 -21.76 -151.34
Oyster Point Pharma, Inc. OYST 596.40 None 5.99 -10.36 None
Mirum Pharmaceuticals, Inc. MIRM 497.00 None 3.23 -7.34 None
SIGA Technologies, Inc. SIGA 489.54 19.00 5.48 -24.87 -94.00
Satsuma Pharmaceuticals, Inc. STSA 488.92 None 4.81 -13.44 None
Imara, Inc. IMRA 483.82 None 4.67 -13.75 None
Biospecifics Technologies Corp. BSTC 443.10 40.00 3.60 18.95 61.80
DURECT Corp. DRRX 418.50 28.00 32.14 -17.31 -82.94
Fulcrum Therapeutics, Inc. FULC 410.55 1.00 6.92 -5.95 None
Crinetics Pharmaceuticals, Inc. CRNX 406.56 1.00 5.13 -6.97 -447.78
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
89bio, Inc. ETNB 386.40 None 4.77 -5.99 None
Relmada Therapeutics, Inc. RLMD 385.02 0.00 5.74 -32.17 -877.66
Kala Pharmaceuticals, Inc. KALA 380.16 6.00 4.16 -4.14 None
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 363.42 232.00 2.76 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 328.95 None 7.78 -5.04 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 280.28 13.00 2.54 -6.20 -333.02
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
AMAG Pharmaceuticals, Inc. AMAG 273.70 321.00 1.05 -0.74 -115.05
Lannett Co., Inc. LCI 268.66 542.00 0.92 -8.84 -5.77
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Spero Therapeutics, Inc. SPRO 254.03 12.00 3.34 -3.12 -656.72
Gritstone Oncology, Inc. GRTS 236.88 4.00 2.12 -2.27 None
Kaleido Biosciences, Inc. KLDO 234.00 None 8.30 -3.20 None
KalVista Pharmaceuticals, Inc. KALV 233.46 12.00 2.58 -7.21 -263.38
Veru, Inc. VERU 218.40 39.00 7.30 -22.40 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Galera Therapeutics, Inc. GRTX 180.25 None 3.37 -2.74 None
Liquidia Technologies, Inc. LQDA 171.38 8.00 10.12 -3.48 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 169.20 None 2.55 -10.97 None
Avenue Therapeutics, Inc. ATXI 167.52 532.00 30.79 -11.51 26.69
Evolus, Inc. EOLS 164.40 45.00 2.95 -1.62 -217.51
Evelo Biosciences, Inc. EVLO 159.36 None 4.08 -1.82 None
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 148.35 None 8.60 -6.79 None
Trevi Therapeutics, Inc. TRVI 138.42 None 2.94 -4.72 None
Harrow Health, Inc. HROW 137.28 51.00 8.80 -5.56 -47.54
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Lyra Therapeutics, Inc. LYRA 133.32 1.00 -1.13 -7.99 -491.16
Aquestive Therapeutics, Inc. AQST 131.88 49.00 -7.60 -1.88 -139.64
PhaseBio Pharmaceuticals, Inc. PHAS 127.31 2.00 2.36 -2.66 None
Mustang Bio, Inc. MBIO 122.40 None 2.86 -2.49 None
NeuBase Therapeutics, Inc. NBSE 121.24 None 50.94 -2.71 None
TFF Pharmaceuticals, Inc. TFFP 117.61 None 4.55 -3.03 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.64 3.00 -2.75 -5.65 -679.19
Eton Pharmaceuticals, Inc. ETON 99.36 1.00 10.82 -4.97 None
Milestone Pharmaceuticals, Inc. MIST 93.00 None 0.92 -1.49 None
Checkpoint Therapeutics, Inc. CKPT 79.60 2.00 6.86 -3.43 -949.53
EyePoint Pharmaceuticals, Inc. EYPT 79.57 26.00 5.62 -1.62 -196.30
Clearside Biomedical, Inc. CLSD 79.54 6.00 10.21 -4.51 -293.61
Xeris Pharmaceuticals, Inc. XERS 78.12 4.00 3.87 -0.60 None
Corvus Pharmaceuticals, Inc. CRVS 75.40 None 1.21 -1.60 None
Baudax Bio, Inc. BXRX 72.00 None -1.96 -1.03 None
Navidea Biopharmaceuticals, Inc. NAVB 68.34 1.00 -50.25 -6.18 -65.13
BiomX, Inc. PHGE 65.45 None 1.72 -1.53 None
Assertio Therapeutics, Inc. ASRT 59.04 192.00 1.02 -0.36 -83.99
Genprex, Inc. GNPX 57.57 None 4.89 -4.21 None
Aridis Pharmaceuticals, Inc. ARDS 56.97 1.00 -23.44 -1.95 -851.00
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 51.66 20.00 1.56 -2.74 -51.58
Eyenovia, Inc. EYEN 45.28 None 4.56 -2.21 None
Edesa Biotech, Inc. EDSA 44.10 0.00 6.28 -0.46 -395.23
Moleculin Biotech, Inc. MBRX 42.69 None 3.71 -4.64 None
Allena Pharmaceuticals, Inc. ALNA 36.34 None 4.79 -0.84 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.75 3.00 4.58 -1.42 -225.89
Mannatech, Inc. MTEX 34.08 156.00 1.44 7.68 3.45
AgeX Therapeutics, Inc. AGE 33.79 2.00 -44.46 -2.78 -658.11
CNS Pharmaceuticals, Inc. CNSP 33.12 None 5.75 -6.09 None
Citius Pharmaceuticals, Inc. CTXR 32.94 None 2.44 -1.91 None
Aileron Therapeutics, Inc. ALRN 32.48 None 4.46 -1.22 None
Acer Therapeutics, Inc. ACER 32.00 3.00 2.34 -1.23 -274.69
Adamis Pharmaceuticals Corp. ADMP 31.30 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.10 None 2.76 -23.89 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.20 0.00 0.88 -0.89 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.96 1.00 8.31 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.69 None 1.29 -0.46 None
Novus Therapeutics, Inc. NVUS 7.39 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 5.05 5.00 1.66 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Block & Leviton Tapped To Lead Biopharma Stock-Drop Suit

2d ago, source: Law360

Block & Leviton LLP will represent a proposed class of shareholders in a suit in California federal court alleging drug developer Gossamer Bio Inc. violated federal securities laws by misleading ...

Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial

8d ago, source: YAHOO!

Aerpio Pharmaceuticals, Inc. (“Aerpio”) (ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases, ARDS associated with COVID-19, and diabetic ...

27,466 Shares in Gossamer Bio Inc (NASDAQ:GOSS) Acquired by Two Sigma Investments LP

3d ago, source: theenterpriseleader.com

Two Sigma Investments LP acquired a new stake in Gossamer Bio Inc (NASDAQ:GOSS) during the first quarter, according to its ...

HC Wainwright Begins Coverage on Gossamer Bio (NASDAQ:GOSS)

4d ago, source: modernreaders.com

HC Wainwright initiated coverage on shares of Gossamer Bio (NASDAQ:GOSS) in a report released on Monday morning, Briefing.com ...

Gossamer Bio Inc.

10d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Coverage Initiated by HC Wainwright for Gossamer Bio (NASDAQ:GOSS)

4d ago, source: Stock Market Daily

Stock analysts at HC Wainwright initiated coverage on shares of  Gossamer Bio (NASDAQ:GOSS) in a report issued on Monday. The ...

Gossamer Bio Inc

11d ago, source: Bloomberg

Gossamer Bio, Inc. operates as a biopharmaceutical company. The Company focuses on discovering, acquiring, and developing therapeutics in the disease areas of immunology, inflammation, and oncology.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.